LQDA FY 2019 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena

LQDALiquidia Corporation

$3B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+198.2% YoY

Gross Profit

$7M90.0% margin

Operating Income

-$47M-580.1% margin

Net Income

-$48M-589.5% margin

EPS (Diluted)

$-2.51

Cash Flow

Operating Cash Flow

-$48M

Free Cash Flow

-$50M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$69M

Total Liabilities

$34M

Stockholders' Equity

$35M

Cash & Equivalents

$56M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$3M	+198.2%
Gross Profit	$7M	$3M	+181.0%
Operating Income	-$47M	-$35M	-34.3%
Net Income	-$48M	-$53M	+10.4%